Breakfast, Exercise and Metabolic Health in Healthy Women

March 31, 2023 updated by: Yung-Chih Chen, National Taiwan Normal University

Impact of Different Pre-exercise Breakfast on Post-exercise Glycaemic Response, Appetite and Energy Balance

This project aims to investigate the impact of acute bout of submaximal exercise under different pre-exercise dietary conditions (fasted state versus high carbohydrate breakfast versus high protein breakfast) on postprandial glycaemic, appetite regulation and energy balance in active healthy women.

Study Overview

Detailed Description

Participants will be asked to arrive to the laboratory between 08:00 and 9:00 am after not eating for between 12-14 hours i.e. in a fasted state (water intake is permitted and encouraged). Participants will then be given one of three test drinks (i.e., breakfast): 1) water only; 2) high carbohydrate drink; or 3) high protein (whey protein) drink. Each of these drinks will also contain 500 mL of water and artificial sweetener. 2 h after breakfast, participants will then exercise on a treadmill for 45 min followed by a 2-h oral glucose tolerance test (OGTT) and 30 min ad libitum lunch intake. Blood samples, blood pressures and questionnaire (e.g., appetite and mood) will be collected in a regular pattern throughout the trials. Cognitive functions will be tested at baseline, pre-exercise and 2 h post-exercise. Energy balance will be assessed using food diary and an accelerometer for the rest of the day after leaving the laboratory until midnight.

Study Type

Interventional

Enrollment (Anticipated)

12

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Healthy physical active women (self-reported regular exercise at least 30 min moderate-intensity 3 times per week)
  • Aged between 30 to 55 years
  • Weight stable for more than 3 months (no change in weight +/- 3%)
  • Non-smoker

Exclusion Criteria:

  • Personal history of/existing diabetes, cardiovascular disease, metabolic disease or dyslipidaemia
  • Taking medications that may influence lipid or carbohydrate metabolism or immune system function
  • Men
  • Physically inactive

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fasted exercise
Fasted prior to exercise
Participants will remain fast (Fasted) 2 h prior to 45 min exercise at 65% VO2max.
Experimental: High protein breakfast exercise
High protein breakfast consumption prior to exercise
Participants will consume a high protein breakfast (Protein) 2 h prior to 45 min exercise at 65% VO2max.
Experimental: High carbohydrate breakfast exercise
High carbohydrate breakfast consumption prior to exercise
Participants will consume a high carbohydrate breakfast (Carbohydrate) 2 h prior to 45 min exercise at 65% VO2max.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolic health
Time Frame: 150 minutes
Changes in postprandial blood glucose and insulin responses (e.g., area under the curve) post-exercise between trials
150 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lipid profile
Time Frame: 150 minutes
Changes in blood triglycerides, cholesterol & NEFA concentrations post-exercise between trials
150 minutes
Gut hormones
Time Frame: 150 minutes
Changes in gut hormones (e.g., GLP-1, PYY and GIP, etc.) responses post-exercise between trials
150 minutes
Inflammation
Time Frame: 305 minutes
Changes in inflammation biomarkers (e.g., IL-6, IL-10 and IL-1ra, etc.) responses during trials
305 minutes
Appetite
Time Frame: 30 minutes
ad libitum lunch energy intake (i.e., kcal) after OGTT between trials
30 minutes
Visual analogue scale (VAS)
Time Frame: 305 minutes
Changes in VAS from 1-100 mm (e.g., appetite & mood, etc.) between trials
305 minutes
Substrate oxidation
Time Frame: 305 minutes
Changes in total energy expenditure (i.e., kcal), lipid oxidation (i.e., kcal) and carbohydrate oxidation (i.e., kcal) between trials including pre-exercise, during exercise and post-exercise period.
305 minutes
Blood pressure
Time Frame: 305 minutes
Changes in blood pressure (e.g., systolic and diastolic blood pressure) during trials
305 minutes
Cognition
Time Frame: 305 minutes
Changes in cognitive performance (e.g., reaction time in milliseconds and accuracy in percentage) during trials
305 minutes
Energy intake
Time Frame: 600 minutes
Changes in energy intake (e.g, total calories) using food diary once participants leaving the laboratory until midnight
600 minutes
Physical activity level
Time Frame: 600 minutes
Changes in physical activity level using an accelerometer to record once participants leaving the laboratory until midnight
600 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yung-Chih Chen, PhD, National Taiwan Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 15, 2022

Primary Completion (Anticipated)

March 1, 2024

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

March 16, 2022

First Submitted That Met QC Criteria

March 25, 2022

First Posted (Actual)

April 4, 2022

Study Record Updates

Last Update Posted (Actual)

April 4, 2023

Last Update Submitted That Met QC Criteria

March 31, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 202012HM031-

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Appetitive Behavior

Clinical Trials on Fasted exercise

3
Subscribe